Financials
- Market Capitalization 18.77 B
- Employee 30 K
- Founded 2020
- CEO Scott A. Smith
- Website www.viatris.com
- Headquarter Delaware, United States
- FIGI BBG00Y4RQNH4
- Industry Fabricantes de medicamentos — especializados y genéricos
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-4.15
Relación precio/flujo de caja
—
Dividendos por acción
0.48
Rendimiento por dividendo, %
3.86
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 442 | ZTS Zoetis Inc. Class A Common Stock | 77.35 USD | +3.12% | -0.19% | +0.45% | -47.14% | 31.96 B USD | ||
| 477 | TAK Takeda Pharmaceutical Company Limited American Depositary Share | 18.04 USD | 0.00% | -0.93% | +5.37% | +27.18% | 28.10 B USD | ||
| 688 | NBIX Neurocrine Biosciences, Inc. - Common Stock | 154.06 USD | -1.19% | +0.98% | -13.93% | +6.25% | 15.66 B USD | ||
| 823 | ELAN Elanco Animal Health Incorporated Common Stock | 24.12 USD | -1.59% | -0.74% | -9.70% | +7.70% | 12.05 B USD |